An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma

In our previous studies, we reported that CD133(+) cancer stem cells (CSCs) were chemoresistant in hepatocellular carcinoma (HCC) and that isocorydine treatment decreased the percentage of CD133(+) CSCs. Here, we found that a derivative of isocorydine (d-ICD) inhibited HCC cell growth, particularly...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Meng, Zhang, Lixing, Ge, Chao, Chen, Lijuan, Fang, Tao, Li, Hong, Tian, Hua, Liu, Junxi, Chen, Taoyang, Jiang, Guoping, Xie, Haiyang, Cui, Ying, Yao, Ming, Li, Jinjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694821/
https://www.ncbi.nlm.nih.gov/pubmed/26327240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694821/
https://www.ncbi.nlm.nih.gov/pubmed/26327240

Ejemplares similares